Free Trial
→ INSANE DRONE FOOTAGE (From Paradigm Press) (Ad)tc pixel Free CUE Stock Alerts

Cue Biopharma (CUE) Earnings Date, Estimates & Call Transcripts

Cue Biopharma logo
$19.82 +0.25 (+1.26%)
As of 09:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Cue Biopharma Earnings Summary

Cue Biopharma released Q2 2026 earnings on August 14, 2026, reporting an EPS of -$24.14, which missed analysts' consensus estimates of -$1.69 by $22.45. Quarterly revenue was reported to be $7.88 million, above the consensus estimate of $3 million. With a trailing EPS of -$27.02, Cue Biopharma's earnings are expected to grow next year, from ($21.79) to ($8.70) per share.

Upcoming Q3
Earnings Date
Nov. 11Before Market OpensEstimated
Consensus EPS
(Aug. 14)
-$1.69
Actual EPS
(Aug. 14)
-$24.14 Missed By -$22.45
Actual Revenue
(Aug. 14)
$7.88M

Q2 2026 Earnings Resources

CUE Upcoming Earnings

Cue Biopharma's Q3 2026 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 13, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Powered by Quartr
Get Cue Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cue Biopharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

CUE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CUE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cue Biopharma Analyst EPS Estimates

Current Year EPS Consensus Estimate
($21.79) EPS
Next Year EPS Consensus Estimate
($8.70) EPS

Cue Biopharma Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/11/2026
(Estimated)		--------
8/14/2026Q2 2026-$1.69-$24.14 -$22.45-$24.14$3.00M$7.88M
5/14/2026Q1 2026-$3.30-$1.08+$2.22-$1.08$2.50M$5.69M
11/12/2025Q3 2025-$90.00-$63.00+$27.00-$0.07$2.29M$2.15M
8/12/2025Q2 2025-$117.00-$81.00+$36.00-$0.09$2.00M$2.95M
5/12/2025Q1 2025-$126.00-$153.00 -$27.00-$0.17$0.90M$0.42M
3/28/2025Q4 2024-$126.00-$117.00+$9.00-$0.13$1.70M$1.80M

Cue Biopharma Earnings - Frequently Asked Questions

Cue Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 11th, 2026 based off last year's report dates. Learn more on CUE's earnings history.

In the previous quarter, Cue Biopharma (NASDAQ:CUE) missed the analysts' consensus estimate of ($1.69) by $22.45 with a reported earnings per share (EPS) of ($24.14). Learn more on analysts' earnings estimate vs. CUE's actual earnings.

Cue Biopharma (NASDAQ:CUE) has a recorded annual revenue of $27.47 million.

Cue Biopharma (NASDAQ:CUE) has a recorded net income of -$26.60 million. CUE has generated -$27.02 earnings per share over the last four quarters.

Cue Biopharma's earnings are expected to grow from ($21.79) per share to ($8.70) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:CUE is sourced from Fiscal.ai, with the most recent quarter reported on 8/14/2026. New results are added as companies report their earnings.
From Our Partners
The AI Infrastructure Play Kevin O'Leary Is Backing
Kevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...
The Tomorrow Investor | Sponsoredtc pixel
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
Trump's crypto bank just got approved
Last month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was...
Crypto 101 Media | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
AI Microcap Teams With Gentex on Next-Gen Military Helmets
Morgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...
Capital Trends | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel